ADORA2A and Cognitive impairment: We observed that subjects with more severe cognitive decline, based on higher CDR scores, had significantly higher levels of A2AR mRNA levels regardless of sex, providing further support for the role of adenosine receptors in the modulation of cognitive function as well as for their potential to serve as therapeutic targets for addressing cognitive deficits.